Breaking News Bar

Business News and Information

Illumina to acquire Peninsula cancer detection biotech Grail in $8 billion deal

The agreement comes after Menlo Park-based Grail filed plans earlier in September to go public later in the year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear